The Culture of Excellence
Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.
“Teoxane has gained a reputation for its innovative, scientifically proven range of aesthetic products.1” We are determined to keep our reputation for major breakthroughs in aesthetic medicine and cosmeceuticals.
TEOSYAL RHA® is a hyaluronic acid dermal filler that was specifically designed to respect the natural dynamic behaviour of the face, preserving personal facial expressions without an unnatural “frozen” appearance.2
TEOSYAL PURESENSE REDENSITY® 2 is an injectable under-eye circle fighter to specifically address under circle cavity and deep hollows under the eyes, an area of concern for many patients.3
Discover Teoxane latest innovation: RHA® topical skin booster*. This pioneering, sterile,cross-linked Hyaluronic Acid - gel is specifically designed for professionals. It can be used as part of or as a complement to an aesthetic procedure (Peeling,laser treatment,Dermabrasion,microneedling…). This non invasive skincare solution maintains aesthetic procedure results.
The products in our comprehensive Cosmeceutical skincare range** are formulated with a similar cross-linked hyaluronic acid to that used in our dermal filler range, TEOSYAL®.
RHA® allows to create a mesh-like layer on the surface to hold and redistribute water, maintain skin integrity and appearance while strengthening the skin barrier.4
Culture of Excellence
For 15 years, our culture of excellence has characterised our relentless focus on efficacy, safety and comfort. Comparative clinical studies have demonstrated outstanding results in terms of performance, duration and safety, immediately after injection and up to 18 months later.3 This culture of excellence is also portrayed through our investments dedicated to our fully integrated manufacturing site in the heart of Geneva where, thanks to our expert R&D teams, we implement cutting edge technology for preparing hyaluronic acid gels with optimal mechanical properties. In recent years, we have transformed our organisation and successfully gone through the FDA’s Pre Market Approval process. Three of our fillers were approved in 2017 in the USA for the correction of moderate to severe dynamic facial wrinkles and folds.
"Our independence allows us to achieve a high level of innovation and excellence. Being independent means that we can invest in long-term R&D projects that will help shape the future of our industry."
Valérie Taupin, Founder & CEO, TEOXANE
*RHA® topical skin booster is a cosmetic product according to European Regulation 1223/2009. Cosmetic products are not designed to be injected.
** TEOXANE Cosmeceuticals range are cosmetic product according to European Regulation 1223/2009. Excepted Radiant Night Peel which is a medical device, class I, according to Directive 93/42/EEC. Cosmeceuticals products are not designed to be injected.
- The European Aesthetic Guide Spring 2015
- Berguiga M, Galatoire O. Tear trough rejuvenation: A safety evaluation of thetreatment by a semi-cross-linked hyaluronic acid filler. Orbit. 2017Feb;36(1):22-26
- TEOXANE Laboratories. Safety and effectiveness of three new dynamic fillers for the treatment of moderate to severe nasolabial folds: an 18-month randomized controlled trial versus competitors
- Ex-Vivo tests performed by an independent laboratory: hydration measures performed on epidermis with microscopic observations of skin's micro-relief